Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
G
George Bardsley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
1.9K
Citations
12
h-index
13
i10-index
George Bardsley is an academic researcher. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Respiratory Support and Mechanisms & Chronic Obstructive Pulmonary Disease (COPD) Research. The author has an h-index of 12, co-authored 19 publications.
ORCID: 0000-0003-0056-4298Papers by this author
worksBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
A multicentre prospective observational study comparing arterial blood gas values to those obtained by pulse oximeters used in adult patients attending Australian and New Zealand hospitals
2020 · BMC Pulmonary Medicine · 49 citations
https://doi.org/10.1186/s12890-019-1007-3
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
2018 · BMC Pulmonary Medicine · 34 citations
https://doi.org/10.1186/s12890-018-0720-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat